Innovative Medicines Initiative: Call 18 & 19 Topics

The Innovative Medicines Initiative website has, in advance of the expected official publication in June released details of upcoming funding opportunities. 

You can read the full article here 

IMI2 - Calls 18 & 19

These topics are now at an advanced stage of development and we hope that these drafts will allow potential applicants to start working actively on proposals and forming consortia.  As they are still in development it is possible that a draft topic may be postponed to a future Call or dropped entirely.

Central repository of digital pathology slides to support the development of artificial intelligence tools 

Future IMI Calls for proposals

The following topics are under consideration for inclusion in future IMI Calls for proposals in the longer term. 

Neurodegeneration and other neuroscience priorities

  • Digital transformation of clinical trial endpoints in pain
  • Placebo effect in pain
  • Psychiatric ratings using intermediate stratified markers -2 (PRISM-2)


  • Psoriatic arthritis

Infection control including vaccines

  • New topic(s) under the AMR accelerator platform

Translational safety

  • Dosing in specific populations

Big data, digital health, clinical trials and regulatory research

  • ROADMAP 2: need and opportunity for public-private collaborative research to continue the RoadMap efforts

Facilitating the translation of advanced therapies to patients in Europe

  • ATMP Patient Registries Outcomes Data and Evidence
  • Innovative Manufacturing of Advanced Therapeutic Medicinal Products, ATMPs

Other enablers of research topics

  • Handling of biologic drug products

More information on these potential topics can be found in this document

Richard Buxbaum - Scotland Europa - NCP Services
Industrial Innovation
Health, Well-being and Life Sciences